What is the issue regarding the marketable securities as per below highlighted in red on Exhibit 2?
See the below information regarding the issue
ANS: Extracted Information from Income statement & Balancesheet are noted below for the year ended 2020 :-
If the proper accounting would be adopted the following entries are required to be passed for the Exhibit II items -
1. Investment A/c Dr. 278697
To Cash A/c 278697
(Being Investments are made or purchased)
2. Cash A/c Dr. 291152
To Investment A/c 278697
To Gain on Sale of Investment 12455
(Being Investment are sold worth $ 278697 at a profit of $ 12455)
BUT, As mentioned in Exhibit II, there were no addition or disposition in Marketable securities from 2019. Since no securities are being sold from year 2019 held till 2021, the possibilities of posting of entry No. 02 regarding sale of investment securities woun't arise at all.
So, the Income statement showing Gain on Sale of Investment of $ 12455 shall also becomes questionable; As no securities are being sold during the year, then from where these gains arise.
The above gain gets included in its Loss before tax, which reduces its loss from operating business. As due to reduced loss, company won't get tax benefit & able to Carry-froward reduced amount of business loss.
Furthermore, the Balancesheet showing the Marketable securities of $ 115200 in its Currents Assets is also not True & Fair Amount, as the entries of investments of $ 278697 as not accounted for. A rectification entry is required to pass by the accountant or Auditor to give the effect of the same in the Finacial Statements.
What is the issue regarding the marketable securities as per below highlighted in red on Exhibit...
Required: 1. What is the amount of Apple’s accounts receivable as of September 30, 2017? 2. Compute Apple’s accounts receivable turnover as of September 30, 2017. 3. How long does it take, on average, for the company to collect receivables for fiscal year ended September 30, 2017? 4. Apple’s most liquid assets include (a) cash and cash equivalents, (b) short-term marketable securities, (c) accounts receivable, and (d) inventory. Compute the percentage that these liquid assets (in total) make up of...
JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Dollars and Shares in Millions Except Per Share Amounts) (Note 1)* 2016 71,890 21,789 50.101 20,067 9.143 29 Sales to customers Cost of products sold Gross profit Selling, marketing and administrative expenses Research and development expense In-process research and development Interest income Interest expense, net of portion capitalized (Note 4) Other (income) expense, net Restructuring (Note 22) Eamings before provision for taxes on income Provision for taxes on income (Note 8)...
JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Dollars and Shares in Millions Except Per Share Amounts) (Note 1)* 2016 71,890 21,789 50.101 20,067 9.143 29 Sales to customers Cost of products sold Gross profit Selling, marketing and administrative expenses Research and development expense In-process research and development Interest income Interest expense, net of portion capitalized (Note 4) Other (income) expense, net Restructuring (Note 22) Eamings before provision for taxes on income Provision for taxes on income (Note 8)...
JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Dollars and Shares in Millions Except Per Share Amounts) (Note 1)* 2016 71,890 21,789 50.101 20,067 9.143 29 Sales to customers Cost of products sold Gross profit Selling, marketing and administrative expenses Research and development expense In-process research and development Interest income Interest expense, net of portion capitalized (Note 4) Other (income) expense, net Restructuring (Note 22) Eamings before provision for taxes on income Provision for taxes on income (Note 8)...
JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Dollars and Shares in Millions Except Per Share Amounts) (Note 1)* 2016 71,890 21,789 50.101 20,067 9.143 29 Sales to customers Cost of products sold Gross profit Selling, marketing and administrative expenses Research and development expense In-process research and development Interest income Interest expense, net of portion capitalized (Note 4) Other (income) expense, net Restructuring (Note 22) Eamings before provision for taxes on income Provision for taxes on income (Note 8)...
4. Perform a SWOT analysis for Fitbit. Based on your assessment of these, what are some strategic options for Fitbit going forward? 5. Analyze the company’s financial performance. Do trends suggest that Fitbit’s strategy is working? 6.What recommendations would you make to Fitbit management to address the most important strategic issues facing the company? Fitbit, Inc., in 2017: Can Revive Its Strategy and It Reverse Mounting Losses? connect ROCHELLE R. BRUNSON Baylor University MARLENE M. REED Baylor University in the...